Cytokines direct the differentiation of naive CD4 + T cells into either IFN-g-producing T h 1 cells or IL-4-producing T h 2 cells. In this study, we analyzed the activation of signal transducer and activator of transcription (STAT)1, STAT3 and STAT5 (together with STAT4 and STAT6), and the expression of the recently identi®ed suppressor of cytokine signalling (SOCS) proteins, in differentiated T h 1 and T h 2 cells, both before and after re-stimulation with anti-CD3 and anti-CD28. In addition to the polarized activation of STAT4 in T h 1 cells and STAT6 in T h 2 cells, we found that STAT3 and STAT5 are selectively activated in T h 1 cells after differentiation. This activation of STAT3 and STAT5 was maintained after TCR re-stimulation. The selective activation of STAT3 and STAT5 in T h 1 cells was associated with differential induction of SOCS molecules. After restimulation, SOCS1 expression was signi®cantly increased in T h 2 cells, but not in T h 1 and nonpolarized`T h ' cells. Additionally, the level of CIS was higher in T h 2 cells compared with T h 1 and T h cells. In contrast, the expression of SOCS3 was higher in T h 1 cells. The differential induction of SOCS proteins was paralleled by the differential expression of cytokines in re-stimulated T h 1 and T h 2 cells (IFN-g and IL-4/IL-13 respectively). Our results suggests that STAT3 and STAT5, possibly regulated by the SOCS proteins, may play a role in the differentiation of T h cells, and in the maintenance of the T h 1 and T h 2 phenotype.
Introduction
Two CD4 + T h subsets have been identi®ed, based on their cytokine pro®le. T h 1 cells express IL-2, IFN-g and tumor necrosis factor-b, whereas T h 2 cells express IL-4, IL-5 and IL-13 (1, 2) . These T h subsets are essential for the regulation and optimization of immune responses against different types of pathogen. T h 1 cells participate in the cell-mediated immune response against intracellular pathogens, whilst T h 2 cells participate in the defence against extracellular pathogens (3) . Overproduction of T h 1 cytokines has been implicated in organ-speci®c autoimmune diseases, such as multiple sclerosis. On the other hand, T h 2 cells are known to be involved in atopic and allergic responses (3, 4) . The differentiation of naive CD4 + T cells into T h effector cells is regulated, mainly, by cytokines (5) . IL-12 promotes T h 1 differentiation through the activation of signal transducer and activator of transcription (STAT)4 and mice lacking either IL-12 or STAT4 exhibit markedly reduced T h 1 responses (6) . In contrast, IL-4 has been shown to drive differentiation towards the T h 2 phenotype by activating the STAT6 signalling pathway. Indeed, T cells from STAT6-de®cient mice fail to develop into T h 2 cells (7) . These T h cell subsets cross-regulate each other through their prototypic cytokines (IL-4 and IFN-g), promoting their own proliferation and differentiation in parallel with the suppression of the opposite T h subset. IFN-g down-regulates IL-4 receptor (IL-4R) expression, whereas IL-4 up-regulates its own receptor and down-regulates IL-12 receptor (IL-12R) expression (8, 9) . This receptor modulation is an important mechanism in determining the differentiation of T h cells.
The identi®cation of T h 1-and T h 2-speci®c transcription factors has led to a deeper understanding of the processes involved in committing T h precursor cells to a particular fate. GATA3 and c-Maf are expressed in developing T h 2 cells, and have been shown to promote IL-4, IL-5 and IL-13 production, and inhibit IFN-g production [reviewed in (10) ]. GATA3 is believed to be induced by STAT6 and possibly affects the fate of T h precursor cells through chromatin remodeling in the vicinity of cytokine genes (11±13). T-bet is speci®cally expressed in differentiating T h 1 cells and induces IFN-g production, whilst also suppressing IL-4 and IL-5 production (14) . A recent study has shown that T-bet is able to promote T h 1 differentiation independently of IL-12/STAT4, by both inducing chromatin remodeling of the IFN-g locus and upregulating IL-12R expression (15) .
Differential expression of cytokine receptors and chromatin remodeling of cytokine genes are both mechanisms by which the T h subset phenotypes are established and maintained. However, the repositioning of cytokine genes close to heterochromatin is not always associated with gene silencing (16) . It has been shown that the IL-4R is present on fully differentiated T h 1 cells and that differentiated T h 2 cells likewise express the IFN-g receptor. However, Huang et al. have shown that IL-4 signalling is impaired in T h 1 cells, with a corresponding reduction in the levels of IL-4 induced STAT6 and Janus kinase (Jak)3 phosphorylation (17) . The mechanisms behind this impairment in cytokine signalling are not fully understood. It is known that STAT4 and STAT6 play a central role in T h 1 and T h 2 differentiation (respectively), and the activation of STAT1, STAT3 and STAT5 has been reported in studies of T h 1 associated autoimmune diseases, such as in¯ammatory bowel disease and rheumatoid arthritis (18±20) This, together with the observation that IL-12 induces STAT5 activation (21) , suggests the possible involvement of these STAT molecules in T h 1 differentiation. STAT1, STAT3 and STAT5 are tightly regulated by suppressor of cytokine signalling (SOCS)1, SOCS3 and CIS; members of the SOCS family of proteins, which consists of eight members (CIS and SOCS1±7) (22) . These SOCS proteins are inhibitors of cytokine signalling (23±25), which are induced by activated STAT proteins and inhibit STAT activation by competing with STAT proteins for binding sites on cytokine receptors and also by inhibiting the activity of Jak proteins. Thus, SOCS proteins participate in a classical negative feedback loop for cytokine signalling. Mice lacking the genes SOCS1, SOCS2 or SOCS3 have been generated, and all exhibit phenotypes associated with the deregulation of cytokine and hormone signalling (26± 30). Collectively, these studies reveal an overlapping induction and function of the SOCS molecules, particularly between SOCS1 and SOCS3 (31) .
Importantly, SOCS proteins are involved in inhibitory crossregulation between different cytokine signalling pathways (32± 34). IFN-g has been shown to inhibit IL-4 mediated STAT6 phosphorylation in human monocytes, at least in part, by inducing expression of SOCS1 (35) . Recent reports have also revealed a role for SOCS proteins in the differentiation of CD4 + T cells into T h 1 and T h 2 cells. It has been noted that IL-6 induces SOCS1 in activated CD4 + T cells and that SOCS1 prevents T h 1 differentiation by inhibiting IFN-g-induced STAT1 activation (33) .
In the present study, we examined the involvement of STAT1, STAT3 and STAT5, as well as SOCS1, SOCS3 and CIS, in the differentiation and maintenance of T h 1 and T h 2 cells. We found that STAT3 and STAT5 were selectively activated in T h 1 cells, both before and after re-stimulation, whilst their negative regulator (SOCS1) was induced in T h 2 cells. These data suggest that the STAT3 and STAT5 pathways may play a role in the regulation and maintenance of T h 1 cell differentiation.
Methods

Cell preparation
Spleens from B10.PL mice (H-2 u ) bred at the School of Medical Sciences, Bristol University were used as a source of CD4 + T cells. Puri®ed CD4 + T cells (>95% CD4 + as determined by FACS analysis) were obtained by positive selection using magnetic beads coated with anti-CD4 mAb (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions.
In vitro differentiation of T h cells
For the generation of unpolarized`T h ' cells, CD4 + T cells were cultured in vitro for 4 days with latex beads (Interfacial Dynamics, Portland, OR) coated with mAb to CD3 (145.2C11; BD PharMingen, San Diego, CA) and CD28 (37.51; BD PharMingen) as previously described (36) , in the presence of rIL-2 (20 U/ml; R & D Systems, Minneapolis, MN). For the differentiation of T h 1 cells, rIL-12 (10 U/ml; R & D Systems) and anti-IL-4 mAb (11B11; 1 mg/ml; BD PharMingen) were also added to the culture. For the differentiation of T h 2 cells, rIL-4 (100 U/ml; R & D Systems) and anti-IFN-g mAb (H22; 1 mg/ml; BD PharMingen) were added instead. After 4 days of differentiation, the T h cells were thoroughly washed and rested in medium alone for 2 h before re-stimulation. The T h subsets were re-stimulated using anti-CD3, anti-CD28-coated latex beads for 6 h.
Cytokine protein levels
Supernatants from the differentiation cultures were tested for IFN-g and IL-4 content by speci®c ELISA according to the manufacturer's instructions (BD PharMingen). All cytokines were quanti®ed with standard curves obtained with known amounts of recombinant mouse cytokines.
Quantitative transcript analysis
RNA was prepared from both non-stimulated puri®ed CD4 + T cells and T h cells stimulated with anti-CD3, anti-CD28-coated latex beads for 6 h or with rIL-4 (100 U/ml) for 30 min. Total RNA was extracted from puri®ed CD4 + T cells using TRIzol (GIBCO, Rockville, MD) according to the manufacturer's instruction and was reversely transcribed using random hexamer primers (Amersham Pharmacia Biotech, Uppsala, Sweden). Quantitative real-time PCR was performed using a LightCycler (Roche Diagnostics, Mannheim, Germany) utilizing SYBR Green 1 (Roche Diagnostics) for the sequenceindependent detection of DNA according to the manufacturer's instructions. In brief, reactions (20 ml) containing 2 ml cDNA, 3 mM MgCl 2 , 150 mg/ml BSA (Roche Diagnostics) and 1 U Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA) were denatured at 95°C for 5 min, followed by 35 cycles of ampli®cation. Primer annealing temperatures ranged between 60 to 65°C. PCR primers included: CIS sense: 5¢-TGG-CTACTGCAGTGCACCTG-3¢; CIS antisense: 5¢-TCCAGCTGT-CACATGCATGC-3¢ (300 bp); SOCS1 sense: 5¢-TTCTTG-GTGCGCGACAGTCG-3¢; SOCS1 antisense: 5¢-ACGTAG-TGCTCCAGCAGCTC-3¢ (160 bp); SOCS3 sense: 5¢-TGT-GTACTCAAGCTGGTGCAC-3¢; SOCS3 antisense: 5¢-CAT-ACTGATCCAGGAACTCC-3¢ (310 bp), and GAPDH sense: 5¢-CATTGACCTCAACTACATGG-3¢; GAPDH antisense: 5¢-GTGAGCTTCCCGTTCAGC-3¢(500 bp).
The data was analyzed using the LightCycler Software 3 (Roche Diagnostics). CIS/SOCS transcript levels were normalized against GAPDH. The RNA preparations were also checked for genomic contamination and the speci®c signals obtained were 10-fold lower compared to the cDNA samples.
SDS±PAGE and western blot analysis
Total cellular lysates from T h cells harvested after 4 days of differentiation (non-stimulated T h cells) and T h cells cultured in normal medium for 2 h and then re-stimulated anti-CD3 and anti-CD28 for 6 h (re-stimulated T h cells) were made from 10 Q 10 6 puri®ed CD4 + T cells according to the method of Hibi et al. (37) . Brie¯y, cells were lysed in 600 ml of cold lysis buffer consisting of 20 mM Tris (pH 7.7), 250 mM NaCl, 3 mM EDTA, 3 mM EGTA and 0.5% NP-40, to which protease and phosphatase inhibitors had been freshly added. After 30 min incubation on ice, the extracts were spun for 10 min in an Eppendorf centrifuge at 4°C to pellet cellular debris. The supernatants were removed and stored at ±70°C.
Western blotting was conducted using standard techniques. Brie¯y, proteins from cellular lysates were separated on 10% SDS±PAGE NOVEX gels (Invitrogen, Carlsbad, CA). Following electrotransfer to supported nitrocellulose membranes (Invitrogen), blots were blocked with 5% non-fat dry milk in TBS/0.1% Tween for 1 h at room temperature. Blots were then incubated overnight at 4°C with the following antibodies: pSTAT3 (B-7) and pSTAT6 (Tyr641) from Santa Cruz Biotechnology (Santa Cruz, CA), pSTAT4 (Y693) from Zymed (South San Francisco, CA), and pSTAT1 (Tyr701) and pSTAT5 (Tyr 694) purchased from New England Biolabs (Beverly, MA). STAT1, STAT3, STAT4, STAT5, STAT6, Jak1 and Jak2 were form Santa Cruz Biotechnology, and pJak1 and pJak2 were form Af®nity Bioreagents (Cambridge, UK). The blots were then washed with TBS/Tween (0.1%) followed by incubation with one of the following secondary antibodies: rabbit anti-mouse±horseradish peroxidase (HRP), swine antirabbit±HRP or rabbit anti-goat±HRP (Dako, Cambridge, UK). Finally the blots were developed using the ECL chemiluminescence detection kit (Amersham Pharmacia Biotech).
RNase protection assay
Cytokine-speci®c, 32 P-labelled (Amersham Pharmacia Biotech) RNA probes were generated through the in vitro translation (Riboquant Transcription Kit; BD PharMingen) of the mouse cytokine probe set mCK1 (BD PharMingen) according to the manufacturer's protocol. Total RNA, puri®ed from anti-CD3 and anti-CD28 re-stimulated non-polarized T h , T h 1 and T h 2 cells (10 mg/sample) or T h subsets stimulated with IL-4 (100 U/ml) and IFN-g (50 ng/ml) for 30 min, was hybridized overnight with the labeled cytokine probes using the Riboquant RPA kit purchased from BD PharMingen and subsequently RNase treated. Protected fragments were resolved on 5% PAGE gels.
Results
Induction of T h 1 and T h 2 differentiation in vitro
Puri®ed CD4 + T cells were cultured under T h 1-and T h 2-polarizing conditions for 4 days. STAT activation and SOCS expression were analyzed before and after re-stimulation with anti-CD3 and anti-CD28. In order to con®rm the T h 1 and T h 2 phenotype, both before and after the re-stimulation, the expression of T h 1-and T h 2-speci®c cytokines was analyzed by ELISA and RNase protection assay (Fig. 1A and B) . The results show distinct patterns of cytokine expression between the different T h subsets, which were consistent both before and after re-stimulation. IFN-g was highly induced in the T h 1 population, but was barely detectable in the T h 2 population (Fig. 1A and B) . In contrast, IL-4 and IL-13 were almost exclusively induced in T h 2 cells (Fig. 1A and B) . A distinct cytokine pro®le was also detected in the non-polarized`T h ' cells, which were cultured in the absence of any exogenous cytokines. These T h cells expressed low levels of IL-2, IL-10 and IFN-g, but no IL-4 or IL-13 ( Fig. 1A and B) . Expression of IL-10 by T h 1 cells was also observed, which is consistent with other recent reports (38±40). These data show that the T cells were polarized, and that the T h 1 and T h 2 phenotypes were maintained after TCR re-stimulation. To further con®rm that the differentiation was stable, differentiated T h 1 and T h 2 cells were cultured in normal medium for 6 h and then stimulated with IFN-g or IL-4 respectively. RNase protection assay results show that exogenously added IL-4 could not induce T h 2 cytokine production by T h 1 cells, neither could IFN-g induce T h 1 cytokine production in T h 2 cells (Fig. 1C) . Therefore, in the absence of polarization conditions, the phenotypes of the differentiated T h 1 and T h 2 cells were stably maintained. http://intimm.oxfordjournals.org/ fully investigated. In order to determine which Jak proteins and STAT proteins are activated in T h 1 and T h 2 cells, total cell lysates from T h 1 and T h 2 cells, both before and after restimulation with anti-CD3/CD28 (see above), were analyzed by immunoblotting with antibodies speci®c to phospho-Jak or phospho-STAT proteins (Fig. 2) .
STAT4 activation was selectively induced in T h 1 cells. In contrast, STAT6 activation was higher in T h 2 cells, both before and after re-stimulation with anti-CD3 and CD28 ( Fig. 2A and  B) . This con®rms the previous ®ndings that STAT4 and STAT6 are involved in the regulation of T h 1 and T h 2 differentiation respectively (41) . In addition to the reciprocal activation of STAT4 and STAT6 in T h 1 and T h 2 cells, the amount of STAT3 and STAT5 phosphorylation was signi®cantly increased in T h 1 cells, but not in T h 2 cells, before and after re-stimulation with anti-CD3 and anti-CD28. This suggests that STAT3 and STAT5 activation in T h 1 cells is not due to the polarization pressure for T h 1 differentiation ( Fig. 2A and B) . Low STAT3 and STAT5 activation in T h 2 cells was associated with increased SOCS1 mRNA levels (see below). STAT1 was predominantly activated in T h 1 cells after polarization; however, all of the T h subsets showed similar levels of STAT1 phosphorylation following re-stimulation ( Fig. 2A and B) .
Since STAT proteins are activated by Jak proteins, the differential activation of STAT proteins in the T h subsets may result from the differential regulation of Jak proteins. For example, SOCS proteins can inhibit Jak/STAT signalling by interacting with and inhibiting the activation of the Jak proteins [reviewed in (42) ]. However, despite the clear differences in STAT3 and STAT5 activation, activation of Jak1 and Jak2 was observed in all T h subsets, although phosphorylation of Jak1 and Jak2 was slightly higher in T h 1 and T h 2 cells compared to non-polarized T h cells (Fig. 3) .
Induction of SOCS molecules in T h , T h 1 and T h 2 cells
The data, thus far, have revealed that STAT3 and STAT5 are activated in T h 1, but not T h 2, cells, and that this selective activation is maintained after TCR re-stimulation. One of the possible mechanisms behind this selective activation of STAT3 and STAT5 is the selective induction of negative regulators for Jak/STAT signalling pathways in T h 1 and T h 2 cells. The SOCS family members are induced by a large variety of stimuli and are potent inhibitors of Jak/STAT signalling (42) . In order to investigate the association of SOCS expression and the selective induction of STAT activation in T h 1 cells, a real-time, quantitative RT-PCR assay The polarized T h subsets were cultured in normal medium for 2 h, then re-stimulated using either (B) anti-CD28, anti-CD3-coated beads for 6 h or (C) IFN-g (50 ng/ml) and IL-4 (100 U/ml) for 30 min. After re-stimulation, cytokine mRNA expression was analyzed by RNase protection assay. The detected cytokines are indicated. was used to examine the SOCS expression pro®les of both T h 1 and T h 2 cells, before and after re-stimulation with anti-CD3/ CD28. No induction of SOCS mRNA was detected in differentiated T h 1 and T h 2 cells before re-stimulation (data not show), in line with another recent report (17) . However, following TCR re-stimulation, the level of SOCS1 mRNA was highly induced in T h 2 cells, compared to T h and T h 1 cells (Fig. 4A) . In addition to the induction of SOCS1 mRNA, the level of CIS mRNA was also increased, to some extent, in T h 2 cells compared to T h 1 cells (Fig. 4A ). SOCS1 and CIS are inhibitors of the STAT5 signalling pathway (43, 44) . Furthermore, SOCS1 is a negative regulator of STAT3 signalling (25) . Thus, the induction of SOCS1 and CIS in T h 2 cells may result in the suppression of STAT3 and STAT5 activation after TCR stimulation, facilitating maintenance of the T h 2 phenotype. In contrast, T h 1 cells showed slightly increased levels of SOCS3 mRNA (Fig. 4A) . These data reveal a difference in SOCS expression between the subsets of T h cells, which may help to explain the differential activation of STAT proteins observed.
In order to examine the involvement of IL-4 in the induction of SOCS1 expression in T h 2 cells, differentiated T cells were washed and then cultured with or without IL-4 or with anti-CD3 and anti-CD28. Interestingly, culturing T h 2 cells in the presence of IL-4 did not affect the expression of SOCS1, compared to media alone. However, when cultured in the presence of anti-CD3 and anti-CD28, a signi®cant increase in SOCS1 expression was observed (Fig. 4B) . TCR re-stimulation did not induce expression of SOCS1 in T h 1 cells. These data suggest that the selective induction of SOCS1 in T h 2 cells is ®rst established during T h 2 differentiation and is then induced upon TCR stimulation. It is possible that SOCS1 expression, induced by TCR re-stimulation, could prevent the TCRinduced expression of IFN-g in T h 2 cells. IFN-g induces SOCS1 expression as a feedback inhibition mechanism. However, SOCS1 expression in T h 1 cells was low, despite the detection of high levels of IFN-g mRNA (Fig. 4A) .
Discussion
It is well established that T h cell differentiation is induced by distinct cytokine signalling pathways [reviewed in (45) ]. However, the mechanisms resulting in the inhibition of T h 2 cytokine production in T h 1 cells and T h 1 cytokines in T h 2 cells are not entirely clear. TCR stimulation of recently differentiated T h 2 cells leads to the production of IL-4, which is neither in¯uenced by the cytokine environment nor dependent on IL-4 signalling (46±48). On the other hand, IFN-g expression by differentiated T h 1 cells appears to be dependent on the cytokines present during re-stimulation (48) . Although the selective expression of IFN-g in T h 1 cells and IL-4 in T h 2 cells may be regulated by non-cytokine-mediated transcription factors, such as T-bet in T h 1 and GATA3 in T h 2 (10), it has been shown that the endogenous production of IL-4 by T h 2 cells renders them unresponsive to IL-12 stimulation. However, if the IL-4 is neutralized in T h 2 cells they do become responsive to IL-12, following treatment with IFN-g. This leads to the subsequent, endogenous, production of IFN-g. IL-4, therefore, appears to function to stabilize the T h 2 phenotype (47). Fig. 3 . Western blot analysis of Jak phosphorylation in T h , T h 1 and T h 2 cells. Cell lysates from differentiated T h cells re-stimulated with anti-CD3/CD28 antibodies for 6 h were resolved on 10% SDS±PAGE gels and transferred to nitrocellulose membranes. The activation of Jak1 and Jak2 was examined using phospho-Jak1-and -Jak2-speci®c antibodies. The results represent one of similar results from three independent experiments. (49, 50) . In this study, we have shown that STAT5 is induced in T h 1 cells after polarization with IL-12 and anti-IL-4, but not in T h 2 cells following polarization by IL-4 and anti-IL-12. STAT5 activation is associated with the production of T h 1 cytokines, which suggests that the regulation of T h 1 development may not be entirely dependent on STAT4. Indeed, IL-12, via the high-af®nity receptor IL-12Rb1/IL12Rb2, induces the activation of Jak2 and Tyk2 (51) , which are known to phosphorylate STAT5. Interestingly, IL-12-mediated STAT5 activation is inhibited by IL-4, but augmented by IFN-g (51) . However, although these results suggest a role for STAT5 in T h 1, but not T h 2, cell differentiation, there is no direct evidence to support this. The suppression of IL-4-induced STAT5 activation in T h 2 cells may be important to prevent the expression of T h 1 cytokines. Most interestingly, the selective activation of STAT3 and STAT5 in T h 1 cells was observed not only after polarization, but also following TCR mediated restimulation, in the absence of IL-12 and anti-IL-4. This suggests that T h 1 associated STAT3 and STAT5 activation is dependent on T h 1 cell differentiation, rather than the direct action of IL-12 on differentiated cells. However, our data does not explain what stimuli trigger the activation of STAT3 and STAT5 in T h 1 cells. A possible candidate could be IL-27, a recently discovered cytokine that has been implicated to play a role in the generation of T h 1 responses (52). However, it is still possible that STAT3 activation in T h 1 cells may result from IL-12 stimulation (41). Interestingly, although IL-10 is induced in both T h 1 and T h 2 cells, IL-10-mediated STAT3 activation could not be detected in T h 2 cells. Thus, STAT3 activation in T h 1 may also be dependent on T h 1 cell differentiation.
In their studies of T h differentiation in STAT5 ±/± mice, Kagami et al. (53) observed that T h 2 development is impaired in STAT5 knockout mice, despite these mice showing normal IL-4-induced activation of STAT6. However, this impaired T h 2 development does not result directly from the lack of STAT5 in T h 2 cells, but from the impaired function of regulatory CD4 + CD25 + T cells, which modulate the development of T h 2 cells (53) . In normal mice, depletion of the CD4 + CD25 + regulatory T cells leads to a decrease in T h 2 cell differentiation, suggesting that STAT5 might be involved in the development of CD4 + CD25 + regulatory T cells (53) . Together with our results, this indicates that STAT5 is not directly involved in T h 2 cell differentiation.
SOCS proteins are negative feedback regulators of the Jak/ STAT signalling pathway, and can thus inhibit signalling by many cytokines, growth factors and hormones (42) . Expression of SOCS1 and SOCS3, the best studied of the SOCS molecules, has been reported to be induced by almost all cytokines investigated (42) . However, despite the distinct phenotypes seen in SOCS1 and SOCS3 knockout mice, the functional differences of these molecules are largely unknown. A possible role for SOCS1 in T h cell polarization in vivo has recently been reported (54) . This study showed a high level of IFN-g and IL-4 expression in SOCS1 ±/± CD4 + T cells after stimulation in vitro with anti-CD3 antibody (54) . It is, therefore, possible that SOCS1 may play a role in the suppression of T h 1 cytokines in T h 2 cells and/or T h 2 cytokines in T h 1 cells. Mice de®cient in SOCS1 suffer from lymphocyte-dependent multiorgan diseases and perinatal death. However, this can be rescued using lymphocytes from either SOCS1/STAT1 or SOCS1/STAT6 double-knockout mice (34) , suggesting that SOCS1 negatively regulates both the IFN-g/STAT1 and IL-4/ STAT6 signalling pathways. The over-activation of IL-4/STAT6 and IFN-g/STAT1 signalling in SOCS1 ±/± CD4 + T cells also suggests a possible role for SOCS1 in the maintenance of T cell homeostasis rather than the regulation of T h differentiation. We have shown here that SOCS1 mRNA is increased in T h 2 cells, compared with T h 1 cells, after re-stimulation with anti-CD3 and anti-CD28 antibodies. The role of SOCS1 in T h 2 cells may be different to that in undifferentiated T cells, because, in addition to the above, SOCS1 expression is associated with the expression of T h 2 cytokines and IL-4-induced STAT6 activation in T h 2 cells. There is also a correlation between SOCS1 is a strong inhibitor of IFN-g signalling (55) . In SOCS1-de®cient mice, IFN-g-induced STAT1 activation is much higher than in wild-type mice (34) . However, despite the TCR-mediated induction of SOCS1 in T h 2 cells, the activation of STAT1 is similar in all T h cell groups, indicating that the function of SOCS1 in T h 2 cells is likely to be associated with the suppression of STAT3 and STAT5 rather than the inhibition of STAT1 activation. CIS also has the capacity to inhibit signalling pathways in which STAT5 participates. Indeed, STAT5 has been shown to induce CIS protein expression. The high level of CIS expression seen in T h 2 cells correlates well with the low level of STAT5 phosphorylation we have detected in our system. These observations are in line with ®ndings in the CIS-transgenic mouse. Mice overexpressing CIS exhibit enhanced T h 2 cell differentiation, in parallel with a decrease in T h 1 cells (44) .
SOCS3, as well as SOCS1, can inhibit IFN-g signalling. Song et al. showed that overexpression of SOCS3 inhibited IFN-ginduced STAT1 phosphorylation and nuclear translocation (55) . SOCS3 has also been found to inhibit IL-4-induced signalling (56). Huang et al. have shown that T h 1 cells have impaired IL-4 signalling. Terminally differentiated T h 1 cells showed no induction of STAT6 phosphorylation in response to IL-4, whereas STAT6 phosphorylation in IL-4-stimulated T h 2 cells was high, despite similar levels of the IL-4R expression on the surface. The authors speculate that the altered sensitivity of T h 1 cells to IL-4 may explain the stability of the T h 1 state. However, the mechanism(s) behind this impairment in IL-4 signalling are not yet known. Indeed, no SOCS1 or SOCS3 mRNA was detected in the T h 1 and T h 2 cells (17) . In line with this ®nding, we could not detect the induction of SOCS1 mRNA in differentiated T h 2 cells in the absence of TCR re-stimulation. The requirement for TCR re-stimulation for the induction of SOCS1 in T h 2 cells suggests a possible role for SOCS1 in maintaining the phenotype of differentiated T h 2 cells. Additionally, we observed higher SOCS3 mRNA levels in T h 1 cells after TCR stimulation. However, although the level of SOCS3 induction in T h 1 is much lower than the level of SOCS1 in T h 2 cells, it is tempting to speculate, as in the case of SOCS1 in T h 2 cells, that SOCS3 in T h 1 cells suppresses possible signalling through the IL-4R. SOCS3 may be induced by IFN-g signalling and subsequently inhibit IL-4 signalling in differentiated T h 1 cells. However, we could not ®nd an association between the suppression of the Jak/STAT pathway and SOCS3 mRNA levels in T h 1 cells. The function of SOCS3 in T h 1 cells may be associated with non-Jak/STAT pathways, although this has yet to be investigated. Recently, Egwuagu et al. found a differential expression of SOCS1 in T h 1 cells and SOCS3 in T h 2 cells before and after re-stimulation with antigen (57) . The contrasting results might re¯ect differences in the conditions under which SOCS1 and SOCS3 expression were examined, i.e. mode of T cell re-stimulation, presence of cytokines in the T h cultures and the kinetics of SOCS expression. Furthermore, these results are also in contrast with the study by Huang et al., who could not detect SOCS1 and SOCS3 mRNA transcripts in non-re-stimulated T h 1 and T h 2 cells (17), which is consistent with our ®ndings. One of the mechanisms by which SOCS molecules inhibit cytokine signalling is through the suppression of cytokineinduced Jak activation. SOCS1 binds to Jak1, Jak2, Jak3 and Tyk2, and subsequently inhibits their activity (24, 25, 58, 59) , and SOCS3 is able to inhibit Jak2 activity following binding to activated cytokine receptors (60) . However, we found no differences in the level of phosphorylation of Jak1 and Jak2 between T h 1 and T h 2 cells. Similar levels of Jak activation were seen in the different T h subsets, despite the differences noted in SOCS mRNA levels. This might be explained if the SOCSmediated suppression of STAT activation in T cells programmed for T h 1 and T h 2 differentiation is not dependent on the inhibition of Jak activity.
The observation that T h 1-and T h 2-speci®c transcription factors such as T-bet and GATA3 promote T h 1 and T h 2 differentiation in the absence of IL-12/STAT4 and IL-4/STAT6 signalling (respectively) suggests that cytokine signalling is only important in the suppression or induction of the T h lineage commitment (15) . The selective activation of STAT3 and STAT5 pathways in T h 1 cells could be an important part of the lineage selection, facilitating the selective expression of cytokines. In the light of this, it is conceivable that STAT5 is highly activated in disease-related T cells in T h 1-associated autoimmunity and is associated with the expression of T h 1 cytokines seen in these conditions.
